"Anal\u00FDza biologick\u00E9 l\u00E9\u010Dby psori\u00E1zy ve FN Hradec Kr\u00E1lov\u00E9 v letech 2006-2011"@cs . . "0009-0514" . . "Biologick\u00E1 l\u00E9\u010Dba psori\u00E1zy je zat\u00EDm nejmodern\u011Bj\u0161\u00ED, nejn\u00E1kladn\u011Bj\u0161\u00ED a vysoce \u00FA\u010Dinn\u00FD zp\u016Fsob l\u00E9\u010Dby tohoto chronick\u00E9ho onemocn\u011Bn\u00ED. V sou\u010Dasn\u00E9 dob\u011B jsou pro l\u00E9\u010Dbu st\u0159edn\u011B t\u011B\u017Ek\u00E9 a\u017E t\u011B\u017Ek\u00E9 lup\u00E9nky v \u010Cesk\u00E9 republice registrov\u00E1ny 4 biologick\u00E9 p\u0159\u00EDpravky: etanercept, adalimumab, infliximab, ustekinumab. Retrospektivn\u00ED anal\u00FDza \u00FA\u010Dinnosti jednotliv\u00FDch biologik z let 2006\u20132011 ve Fakultn\u00ED nemocnici v Hradci Kr\u00E1lov\u00E9 neuk\u00E1zala statisticky signifikantn\u00ED rozd\u00EDly mezi jednotliv\u00FDmi prepar\u00E1ty v \u00FA\u010Dinnosti po prvn\u00EDch 3 m\u011Bs\u00EDc\u00EDch l\u00E9\u010Dby. Nej\u010Dast\u011Bj\u0161\u00EDm d\u016Fvodem k ukon\u010Den\u00ED l\u00E9\u010Dby byla ztr\u00E1ta terapeutick\u00E9ho efektu (v 57,3 %), bez komplikac\u00ED a ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F prob\u00EDhala biologick\u00E1 l\u00E9\u010Dba u 54,8 % l\u00E9\u010Den\u00FDch." . "side effects; efficacy; biological therapy of psoriasis"@en . "Anal\u00FDza biologick\u00E9 l\u00E9\u010Dby psori\u00E1zy ve FN Hradec Kr\u00E1lov\u00E9 v letech 2006-2011" . . "Anal\u00FDza biologick\u00E9 l\u00E9\u010Dby psori\u00E1zy ve FN Hradec Kr\u00E1lov\u00E9 v letech 2006-2011"@cs . . "2946" . "5"^^ . "\u010Cesko-slovensk\u00E1 dermatologie" . "RIV/00216208:11120/14:43908603!RIV15-MSM-11120___" . "I, S" . "Anal\u00FDza biologick\u00E9 l\u00E9\u010Dby psori\u00E1zy ve FN Hradec Kr\u00E1lov\u00E9 v letech 2006-2011" . . "Analysis of Biological Therapy of Psoriasis in Faculty Hospital Hradec Kr\u00E1lov\u00E9 in 2006-2011"@en . "Ettler, Ji\u0159\u00ED" . "CZ - \u010Cesk\u00E1 republika" . "11120" . "Analysis of Biological Therapy of Psoriasis in Faculty Hospital Hradec Kr\u00E1lov\u00E9 in 2006-2011"@en . "RIV/00216208:11120/14:43908603" . . . "Biologick\u00E1 l\u00E9\u010Dba psori\u00E1zy je zat\u00EDm nejmodern\u011Bj\u0161\u00ED, nejn\u00E1kladn\u011Bj\u0161\u00ED a vysoce \u00FA\u010Dinn\u00FD zp\u016Fsob l\u00E9\u010Dby tohoto chronick\u00E9ho onemocn\u011Bn\u00ED. V sou\u010Dasn\u00E9 dob\u011B jsou pro l\u00E9\u010Dbu st\u0159edn\u011B t\u011B\u017Ek\u00E9 a\u017E t\u011B\u017Ek\u00E9 lup\u00E9nky v \u010Cesk\u00E9 republice registrov\u00E1ny 4 biologick\u00E9 p\u0159\u00EDpravky: etanercept, adalimumab, infliximab, ustekinumab. Retrospektivn\u00ED anal\u00FDza \u00FA\u010Dinnosti jednotliv\u00FDch biologik z let 2006\u20132011 ve Fakultn\u00ED nemocnici v Hradci Kr\u00E1lov\u00E9 neuk\u00E1zala statisticky signifikantn\u00ED rozd\u00EDly mezi jednotliv\u00FDmi prepar\u00E1ty v \u00FA\u010Dinnosti po prvn\u00EDch 3 m\u011Bs\u00EDc\u00EDch l\u00E9\u010Dby. Nej\u010Dast\u011Bj\u0161\u00EDm d\u016Fvodem k ukon\u010Den\u00ED l\u00E9\u010Dby byla ztr\u00E1ta terapeutick\u00E9ho efektu (v 57,3 %), bez komplikac\u00ED a ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F prob\u00EDhala biologick\u00E1 l\u00E9\u010Dba u 54,8 % l\u00E9\u010Den\u00FDch."@cs . "Biological therapy of psoriasis is modern, expensive and highly effective therapeutical modality for this chronic disease. Currently, there are 4 biologics registered for the treatment of severe psoriasis in the Czech Republic: etanercept, adalimumab, infliximab and ustekinumab. Retrospective analysis performed in the Faculty Hospital Hradec Kr\u00E1lov\u00E9 in the period 2006\u20132011 did not show statistically significant difference of efficacy among biologics used after the first three months of therapy. The main reason for therapy discontinuation was loss of efficacy (57,3 %). No complications and side effects were recorded in 54,8 % of patients."@en . . . "1"^^ . "[7FF76363CC5B]" . . . . "2"^^ . "89" . "3" . . . .